Inventor · disambiguated record
Wolfgang Froestl
Also filed as: FROESTL WOLFGANG
11 granted patents·7 pending applications·30 citations·filing 2003–2015
86Inventor score
Top patents by PatentIndex Score
18 records- 0185US9221812B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsKROTH HEIKO·Filed 2011·Granted Dec 29, 2015·15 cites·18 claims
- 0275US9701660B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemAC IMMUNE SA·Filed 2014·Granted Jul 11, 2017·2 cites·8 claims
- 0375US7655666B2Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligandsNOVARTIS AG·Filed 2006·Granted Feb 2, 2010·2 cites·5 claims
- 0473US8916590B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemKROTH HEIKO·Filed 2010·Granted Dec 23, 2014·2 cites·13 claims
- 0571US8299085B2Quinazoline derivativesALLGEIER HANS·Filed 2005·Granted Oct 30, 2012·2 cites·6 claims
- 0670US8673940B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsFROESTL WOLFGANG·Filed 2012·Granted Mar 18, 2014·4 cites·7 claims
- 0768US8513268B21H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsyALLGEIER HANS·Filed 2011·Granted Aug 20, 2013·1 cites·6 claims
- 0867US10662193B2Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted May 26, 2020·1 cites·14 claims
- 0967US10500207B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted Dec 10, 2019·1 cites·18 claims
- 1067US8012988B2N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamideNOVARTIS AG·Filed 2009·Granted Sep 6, 2011·0 cites·12 claims
- 1157US2013296332A11h-quinazoline-2,4-dionesNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1247US7498319B2Phosphinic acid derivativesNOVARTIS AG·Filed 2004·Granted Mar 3, 2009·0 cites·17 claims
- 1346US2010144793A1Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2007·Application pending·0 cites
- 1445US2010183513A1N-(methyl) -1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer'sFROESTL WOLFGANG·Filed 2007·Application pending·0 cites
- 1539US2006142249A1Ophthalmic useFROESTL WOLFGANG·Filed 2003·Application pending·0 cites
- 1636US2010179127A1Pyrimidine derivativesFLOERSHEIM PHILIPP·Filed 2006·Application pending·0 cites
- 1734US2011256064A1Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like ProteinsAC IMMUNE SA·Filed 2011·Application pending·0 cites
- 1833US2014018376A1Use of 1H-Quinazoline-2,4-DionesALLGEIER HANS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolfgang Froestl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →